Position in QGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,723,000
+$11,513,800 QoQ
Shares Held
530,000
+130.4% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#50
of 336 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Derivatives in QGEN
reported options exposure · as of Jun 30, 2026CallValue
$19,550,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Longaeva Partners L.P. holds $76,720,663 across 3 Diagnostics & Research names. QGEN ranks #2 (27.0% of the industry book) .
All Filings in QGEN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,723,000 | 530,000 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $19,550,000 | 500,000 | Call | Other | 2026-08-14 | |
| 2026-03-31 | $9,209,200 | 230,000 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||